Case File №
#VI-2026-0341
Changan District Sheng Peptide Trading
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
38 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E Bad | 7 | 6.2 | 0.0 | 9.7 | 10 Sep 2025 |
| 5-amino-1MQ | X N/A | 1 | 5.3 | 5.3 | 5.3 | 16 Mar 2025 |
| Abaloparatide | X N/A | 1 | 4.0 | 3.8 | 3.8 | 7 May 2025 |
| AHK-CU | X N/A | 1 | 5.7 | 5.7 | 5.7 | 20 Jun 2025 |
| AICAR | X N/A | 1 | 7.0 | 7.0 | 7.0 | 11 Jun 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 4.0 | 3.1 | 3.1 | 27 Feb 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 1 | 7.7 | 7.7 | 7.7 | 20 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 5.6 | 5.6 | 5.6 | 28 Mar 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| Cartalax | X N/A | 1 | 6.4 | 6.4 | 6.4 | 20 Jun 2025 |
| Chonluten | X N/A | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 |
| CJC-1295 With DAC | X N/A | 1 | 5.0 | 5.0 | 5.0 | 25 Apr 2025 |
| Deca (Nandrolone Decanoate) | X N/A | 1 | 7.7 | 7.7 | 7.7 | 24 Apr 2025 |
| Dianabol Oil | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| Epithalon | X N/A | 1 | 4.0 | 3.6 | 3.6 | 8 Jul 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 5.4 | 5.4 | 5.4 | 28 Mar 2025 |
| Hexarelin | X N/A | 1 | 4.5 | 4.5 | 4.5 | 2 Jul 2025 |
| Humanin | X N/A | 1 | 4.0 | 3.9 | 3.9 | 13 Feb 2025 |
| Hyaluronic acid | X N/A | 1 | 6.0 | 6.0 | 6.0 | 20 Jun 2025 |
| Letrozole | X N/A | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 |
| Methylene Blue | X N/A | 1 | 4.2 | 4.2 | 4.2 | 6 May 2025 |
| Oxymetholone (Anadrol) Raw | X N/A | 1 | 4.0 | 3.3 | 3.3 | 7 May 2025 |
| P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 2 Jul 2025 |
| Pinealon | X N/A | 1 | 8.6 | 8.6 | 8.6 | 24 Apr 2025 |
| PNC 27 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 |
| Prednisone | X N/A | 1 | 6.0 | 6.0 | 6.0 | 13 Feb 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 8 Jul 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 5.3 | 5.3 | 5.3 | 3 Jun 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 7.4 | 7.4 | 7.4 | 25 Apr 2025 |
| Superdrol | X N/A | 1 | 6.1 | 6.1 | 6.1 | 14 Jan 2025 |
| T3 (Liothyronine) | X N/A | 1 | 6.2 | 6.2 | 6.2 | 21 May 2025 |
| Tadalafil Raw | X N/A | 1 | 6.9 | 6.9 | 6.9 | 21 May 2025 |
| Test Suspension | X N/A | 1 | 4.0 | 3.3 | 3.3 | 11 Jun 2025 |
| Testagen | X N/A | 1 | 7.6 | 7.6 | 7.6 | 16 Mar 2025 |
| Tren Hex | X N/A | 1 | 5.4 | 5.4 | 5.4 | 14 Jan 2025 |
| Turinabol | X N/A | 1 | 7.5 | 7.5 | 7.5 | 9 Jun 2025 |
| Vitamin D3 20000iu/ml | X N/A | 1 | 7.1 | 7.1 | 7.1 | 11 Jun 2025 |
Exhibit II
Evidence Log
44 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Oxymetholone (Anadrol) Raw | 5.0 B | 1g | 0.9g | -8.4% | 98.32% | 4l4uyp | Lab B | Community |
| 24 May 2026 | Cartalax | 7.4 A | 50mg | 50.5mg | +1.0% | 97.03% | xfb0qw | Lab B | Community |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.9 C | 5mg | 5.2mg | +3.0% | 95.01% | 5qpry8 | Lab C | Community |
| 24 May 2026 | Turinabol | 9.1 A | 50mg | 53.8mg | +7.6% | 95.30% | ro8fsq | Lab A | Community |
| 24 May 2026 | Letrozole | 5.2 B | 25mg | 28.8mg | +15.1% | 97.77% | 86ln26 | Lab E | Public |
| 24 May 2026 | Deca (Nandrolone Decanoate) | 8.4 A | 100mg/ml | 92.2mg/ml | -7.8% | 95.80% | jchlfy | Lab F | Public |
| 23 May 2026 | Hexarelin | 4.0 C | 10mg | 9.3mg | -6.9% | 96.80% | b90day | Lab B | Public |
| 23 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 7.8 A | 200mg/ml | 198.3mg/ml | -0.8% | 98.08% | tb3qxm | Lab C | Community |
| 22 May 2026 | Retatrutide | 4.7 D | 20mg | 11.5mg | -42.5% | 99.88% | n/a | White Label / Silver Crimp / Yellow Cap | Lab E |
| 22 May 2026 | Retatrutide | 4.6 D | 20mg | 11.8mg | -41.0% | 99.85% | n/a | White Label / Silver Crimp / Yellow Cap | Lab E |
| 20 May 2026 | BPC157 10mg + TB500 10mg Blend | 6.8 A | 50mg | 47.2mg | -5.7% | 96.99% | w5asft | Lab C | Community |
| 20 May 2026 | PNC 27 | 7.8 A | 10mg | 11.6mg | +15.7% | 99.06% | uied05 | Lab E | Community |
| 17 May 2026 | Epithalon | 4.0 C | 30mg | 26.5mg | -11.8% | 95.40% | ta1fm1 | Lab G | Public |
| 17 May 2026 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 6.0 A | 100g | 119.3g | +19.3% | 95.15% | dvcsbj | Lab D | Public |
| 17 May 2026 | Superdrol | 7.8 A | 10mg | 11.8mg | +17.7% | 96.10% | 5gky3u | Lab E | Public |
| 29 Jan 2026 | Botulinum toxin | 4.7 C | 10mg | 9.4mg | -5.6% | 96.38% | lhbmob | Lab B | Public |
| 29 Jan 2026 | Tadalafil Raw | 7.4 A | 1g | 0.9g | -9.4% | 98.57% | anf59y | Lab F | Public |
| 26 Jan 2026 | Hyaluronic acid | 8.6 A | 15mg | 18.1mg | +20.6% | 99.44% | fpdj1s | Lab A | Public |
| 19 Jan 2026 | Proviron (Mesterolone) | 5.4 B | 10mg | 9.8mg | -2.1% | 97.90% | v5ywrc | Lab A | Public |
| 7 Jan 2026 | Abaloparatide | 4.0 C | 5mg | 4.8mg | -3.9% | 98.16% | w808qo | Lab A | Public |
| 7 Jan 2026 | Aromasin (Exemestane) | 4.0 C | 25mg | 28.4mg | +13.5% | 96.58% | 8rkbkg | Lab E | Public |
| 29 Dec 2025 | CJC-1295 With DAC | 5.3 B | 5mg | 6.1mg | +21.1% | 95.63% | zre0qw | Lab A | Public |
| 29 Dec 2025 | Dianabol Oil | 5.8 B | 300mg/ml | 349.4mg/ml | +16.5% | 96.64% | e05pxc | Lab B | Community |
| 22 Dec 2025 | Retatrutide | 0.0 E | 20mg | ⚠️ Sample does not contain Retatrutide ? | not detected | (no batch ID) | White Label / Gold Crimp / Clear Cap | Public | — |
| 12 Dec 2025 | Tren Hex | 5.9 B | 200mg/ml | 231.5mg/ml | +15.7% | 99.90% | x0yisb | Lab C | Public |
| 5 Dec 2025 | AICAR | 4.7 C | 5mg | 6.2mg | +23.1% | 98.42% | lelyrf | Lab A | Public |
| 5 Dec 2025 | Methylene Blue | 5.1 B | 10mg | 11.6mg | +15.8% | 97.71% | foe4cj | Lab B | Public |
| 25 Nov 2025 | Retatrutide | 8.0 A | 20mg | 20.1mg | +0.5% | 99.95% | n/a | No Label / Gold Crimp / Clear Cap | Lab E |
| 23 Nov 2025 | Test Suspension | 4.5 C | 300mg/ml | 303.0mg/ml | +1.0% | 95.57% | 1al3uy | Lab A | Public |
| 17 Nov 2025 | 5-amino-1MQ | 4.0 C | 30mg | 32.0mg | +6.7% | 95.31% | j82s98 | Lab D | Public |
| 17 Nov 2025 | Chonluten | 6.3 A | 50mg | 59.3mg | +18.6% | 98.75% | olyoxd | Lab D | Public |
| 17 Nov 2025 | Retatrutide 30mg Pen Kit | 7.9 A | 50mg | 58.5mg | +17.0% | 98.85% | i6hiff | Lab G | Public |
| 17 Nov 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 9.8 A | 30mg | 29.8mg | -0.8% | 96.39% | 38f0yh | Lab F | Public |
| 5 Nov 2025 | AHK-CU | 8.0 A | 20mg | 24.2mg | +21.1% | 96.90% | b463fc | Lab C | Community |
| 5 Nov 2025 | Pinealon | 7.6 A | 15mg | 18.5mg | +23.6% | 98.83% | np66k3 | Lab E | Community |
| 17 Oct 2025 | Prednisone | 7.1 A | 25mg | 23.7mg | -5.0% | 99.14% | ovuw0z | Lab B | Public |
| 17 Oct 2025 | Vitamin D3 20000iu/ml | 5.4 B | 200mg/ml | 230.4mg/ml | +15.2% | 97.17% | baovbz | Lab D | Community |
| 9 Oct 2025 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 7.8 A | 100mg/ml | 91.1mg/ml | -8.9% | 99.74% | tgb1td | Lab A | Public |
| 9 Oct 2025 | T3 (Liothyronine) | 5.4 B | 25mg | 21.9mg | -12.3% | 95.25% | evfrx8 | Lab D | Public |
| 5 Oct 2025 | Retatrutide | 9.7 A | 15mg | 14.6mg | -2.7% | 99.79% | n/a | No Label / Silver Crimp / Orange Cap | Lab E |
| 3 Oct 2025 | Humanin | 4.0 C | 15mg | 18.7mg | +24.4% | 96.03% | a2ncmw | Lab F | Public |
| 3 Oct 2025 | Testagen | 8.2 A | 2mg | 2.5mg | +23.3% | 99.32% | 9tf4v8 | Lab A | Community |
| 30 Sep 2025 | Retatrutide | 9.6 A | 10mg | 9.39mg | -6.1% | 99.93% | n/a | No Label / Silver Crimp / Clear Blue Cap | Lab E |
| 10 Sep 2025 | Retatrutide | 7.0 A | 20mg | 18.4mg | -8.0% | 99.95% | n/a | No Label / Gold Crimp / Clear Cap | Lab E |
— END OF EVIDENCE LOG —